Global Antibody Market by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Antibody-drug Complexes), By End-User (Hospitals, Long-term Care Facilities, Research Institutes), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019-2028
- account_circleAbout Me
- 21236
- $3,495.00
- $5,100.00
- $7,200.00
Market.us announces the publication of its most recently generated research report titled, “Global Antibody Market by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Antibody-drug Complexes (ADCs)), By End-User (Hospitals, Long-term Care Facilities, Research Institutes), and by Region – Global Forecast to 2028.”, Which offers a holistic view of the global antibody market through systematic segmentation that covers every aspect of the target market.
The global antibody market is projected to be US$ 133,348.1 Mn in 2018 to reach US$ 300,777.2 Mn by 2028 at a CAGR of 8.5%.
Antibodies also referred to as immunoglobulins, are secreted through B cells to neutralize antigens such as bacteria and viruses. Generally, all antibodies are of the same Y shaped the molecular structure of four polypeptides, with two heavy chains and two light chains. Each Y tip consists of a paratope (a structure analogous to a lock) that is specific for one particular epitope (similarly analogous to a key) on an antigen allowing these structure to bind together with precision. The ability of binding to an antigen has led to their abundant use in a variety of life sciences and medical science. These antibodies are classified into two types monoclonal and polyclonal, according to how they are created from lymphocytes. Each of them has important role in the immune system, treatments and diagnostics exam.
trending_up Total Revenue in 2018$ 133,348.1 Mn
trending_up Market CAGR of the Next Ten Years8.5%
no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.- By Type
- By Region
- By Application
no_encryption Leading Companies Financial HighlightsPurchase this report or a membership to unlock the leading companies financial highlights for this industry.trending_up Market Revenue of the Next Ten Years$ 300,777.2 Mn
Both monoclonal and polyclonal antibodies have different advantages and disadvantages. Production time required for polyclonal antibodies is short; also they are low in cost. They are highly stable and tolerant of pH changes. Polyclonal antibodies have high affinity. Also, they are less sensitive to antigen changes as compared to monoclonal antibodies. Monoclonal antibodies have highly specific recognition of only one epitope of an antigen. They have high consistency among experiments. Monoclonal antibodies are excellent for affinity purification.
The antibody market is expected to grow in forecasted years and demand for these services is expected to remain steady in emerging economies owing to the favourable economic environment. Robust growth in the pharmaceuticals industry, particularly in developing economies is creating several opportunities in this market. Also, increased research activities in life sciences industries, coupled with growing proteomics and genomics research is further expected to propel market growth.
Antibodies hold diverse applications since these are widely used in autoimmune disorders, oncology, CNS disorders, neurobiology, cardiovascular disease, and other research areas, resulting in the stable growth of the market worldwide. Increase in research funding and increasing investments by pharmaceuticals and biotechnology companies is further supporting the growth of the market. Rapid growth in developing countries and increasing demand for personalized therapeutics are expected to offer significant growth opportunities for market players over the forecast period.
Global Antibody Market Revenue (US$ Mn), 2018–2028
Monoclonal antibodies segment accounts for more significant market share since these provide high specificity, selectivity and ease of production, as compared to other antibodies; and are thus a preferred choice in all types of research studies, which is providing opportunities for target market growth.
Robust growth in pharmaceuticals and biotechnology industries is a major factor driving the growth of the global antibody market.Global Antibody Market by Formulation, 2018
On the basis of product type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies and Antibody-drug Complexes (ADCs). Monoclonal Antibodies accounts for the majority share in the global antibody market.
On the basis of region, the market is segmented into North America, Europe, APAC, South America and MEA. North America accounts for the majority share in the global antibody market, followed by Europe. Emerging economies such as China and India are expected to register the highest growth rate over the forecast period. Countries and regions such as Japan, Southeast Asia and the rest of the world are expected to register stable growth over the forecast period.
The research report on the global antibody market includes profiles of some of the major companies such as Novartis AG, Roche Holding AG, Johnson & Johnson, Takeda Pharmaceutical Company, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc. etc.
Key Market Segments:
Type
- Monoclonal antibodies
- Polyclonal antibodies
- Antibody drug conjugates
Application
- Hospitals
- Long-term care facilities
- Research institutes
Key Market Players included in the report:
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Takeda Pharmaceutical Company
- Amgen Inc.
- Biogen Inc.
- Bristol-Myers Squibb Company
- AbbVie Inc.
For the Antibody Market research study, the following years have been considered to estimate the market size:
Particular Scope Region - North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Historic Year 2015 to 2020 Estimated Year 2021 Forecast Year 2022 to 2031 - account_circleAbout Me
- 21236
- $3,495.00
- $5,100.00
- $7,200.00
- Chapter 1 Global Antibody Market Overview
- 1.1 Introduction
- 1.2 Drivers
- 1.3 Restraints
- 1.4 Opportunities
- 1.5 Trends
- 1.6 Global Antibody Market by Product Type
- 1.6.1 Global Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 1.6.2 Global Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 1.6.3 Global Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 1.7 Global Antibody Market by End User
- 1.7.1 Global Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 1.7.2 Global Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 1.7.3 Global Antibody Market Attractiveness Analysis by End User, 2012–2018
- 1.8 Global Antibody Market Outlook by Region
- 1.8.1 Global Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 1.8.2 Global Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 1.8.3 Global Antibody Market Attractiveness Analysis by Region, 2012–2018
- 1.9 Global Antibody Market Outlook (2012-2028)
- 1.9.1 Global Antibody Revenue (US$ Mn) (2012-2019)
- 1.9.2 Global Antibody Revenue (US$ Mn) (2020-2028)
- 1.10 Global Antibody Revenue (US$ Mn) by Regions
- 1.10.1 Global Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 1.10.2 Global Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 1.11 Global Antibody Revenue (US$ Mn) by Product Type
- 1.11.1 Global Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 1.11.2 Global Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 1.12 Global Antibody Revenue (US$ Mn) by End User
- 1.12.1 Global Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 1.12.2 Global Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 1.13 Global Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 1.13.1 Global Antibody Y-o-Y Growth Rate by Region
- 1.13.2 Global Antibody Market Y-o-Y Growth Rate by Product Type
- 1.13.3 Global Antibody Y-o-Y Growth Rate by End User
- 1.14 Global Antibody Share Comparison 2013–2028
- 1.14.1 Global Antibody Share by Region
- 1.14.2 Global Antibody Market Share by Product Type
- 1.14.3 Global Antibody Share by End User
- Chapter 2 Global Antibody Market Insights
- 2.1 PEST ANALYSIS
- 2.2 PORTER'S Five Forces Analysis
- 2.3 Macro-Economic Factors
- 2.4 Market Investment Feasibility Analysis
- 2.5 Approved Monoclonal Antibody Drugs by Indication
- 2.6 Approved Monoclonal Antibody Drugs (1985 – 2017)
- 2.7 Opportunity Map Analysis
- 2.7.1 Optimistic Scenario
- 2.7.2 Likely Scenario
- 2.7.3 Conservative Scenario
- 2.8 Market Competition Scenario Analysis
- 2.9 Opportunity Orbits
- Chapter 3 North America Antibody Market Overview
- 3.1 North America Antibody Market by Product Type
- 3.1.1 North America Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 3.1.2 North America Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 3.1.3 North America Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 3.2 North America Antibody Market by End User
- 3.2.1 North America Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 3.2.2 North America Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 3.2.3 North America Antibody Market Attractiveness Analysis by End User, 2012–2018
- 3.3 North America Antibody Market Outlook by Region
- 3.3.1 North America Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 3.3.2 North America Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 3.3.3 North America Antibody Market Attractiveness Analysis by Region, 2012–2018
- 3.4 North America Antibody Market Outlook (2012-2028)
- 3.4.1 North America Antibody Revenue (US$ Mn) (2012-2019)
- 3.4.2 North America Antibody Revenue (US$ Mn) (2020-2028)
- 3.5 North America Antibody Revenue (US$ Mn) by Regions
- 3.5.1 North America Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 3.5.2 North America Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 3.6 North America Antibody Revenue (US$ Mn) by Product Type
- 3.6.1 North America Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 3.6.2 North America Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 3.7 North America Antibody Revenue (US$ Mn) by End User
- 3.7.1 North America Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 3.7.2 North America Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 3.8 North America Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 3.8.1 North America Antibody Y-o-Y Growth Rate by Region
- 3.8.2 North America Antibody Market Y-o-Y Growth Rate by Product Type
- 3.8.3 North America Antibody Y-o-Y Growth Rate by End User
- 3.9 North America Antibody Share Comparison 2013–2028
- 3.9.1 North America Antibody Share by Region
- 3.9.2 North America Antibody Market Share by Product Type
- 3.9.3 North America Antibody Share by End User
- 3.1 North America Antibody Market by Product Type
- Chapter 4 Europe Antibody Market Overview
- 4.1 Europe Antibody Market by Product Type
- 4.1.1 Europe Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 4.1.2 Europe Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 4.1.3 Europe Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 4.2 Europe Antibody Market by End User
- 4.2.1 Europe Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 4.2.2 Europe Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 4.2.3 Europe Antibody Market Attractiveness Analysis by End User, 2012–2018
- 4.3 Europe Antibody Market Outlook by Region
- 4.3.1 Europe Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 4.3.2 Europe Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 4.3.3 Europe Antibody Market Attractiveness Analysis by Region, 2012–2018
- 4.4 Europe Antibody Market Outlook (2012-2028)
- 4.4.1 Europe Antibody Revenue (US$ Mn) (2012-2019)
- 4.4.2 Europe Antibody Revenue (US$ Mn) (2020-2028)
- 4.5 Europe Antibody Revenue (US$ Mn) by Regions
- 4.5.1 Europe Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 4.5.2 Europe Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 4.6 Europe Antibody Revenue (US$ Mn) by Product Type
- 4.6.1 Europe Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 4.6.2 Europe Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 4.7 Europe Antibody Revenue (US$ Mn) by End User
- 4.7.1 Europe Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 4.7.2 Europe Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 4.8 Europe Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 4.8.1 Europe Antibody Y-o-Y Growth Rate by Region
- 4.8.2 Europe Antibody Market Y-o-Y Growth Rate by Product Type
- 4.8.3 Europe Antibody Y-o-Y Growth Rate by End User
- 4.9 Europe Antibody Share Comparison 2013–2028
- 4.9.1 Europe Antibody Share by Region
- 4.9.2 Europe Antibody Market Share by Product Type
- 4.9.3 Europe Antibody Share by End User
- 4.1 Europe Antibody Market by Product Type
- Chapter 5 South America Antibody Market Overview
- 5.1 South America Antibody Market by Product Type
- 5.1.1 South America Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 5.1.2 South America Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 5.1.3 South America Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 5.2 South America Antibody Market by End User
- 5.2.1 South America Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 5.2.2 South America Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 5.2.3 South America Antibody Market Attractiveness Analysis by End User, 2012–2018
- 5.3 South America Antibody Market Outlook by Region
- 5.3.1 South America Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 5.3.2 South America Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 5.3.3 South America Antibody Market Attractiveness Analysis by Region, 2012–2018
- 5.4 South America Antibody Market Outlook (2012-2028)
- 5.4.1 South America Antibody Revenue (US$ Mn) (2012-2019)
- 5.4.2 South America Antibody Revenue (US$ Mn) (2020-2028)
- 5.5 South America Antibody Revenue (US$ Mn) by Regions
- 5.5.1 South America Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 5.5.2 South America Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 5.6 South America Antibody Revenue (US$ Mn) by Product Type
- 5.6.1 South America Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 5.6.2 South America Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 5.7 South America Antibody Revenue (US$ Mn) by End User
- 5.7.1 South America Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 5.7.2 South America Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 5.8 South America Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 5.8.1 South America Antibody Y-o-Y Growth Rate by Region
- 5.8.2 South America Antibody Market Y-o-Y Growth Rate by Product Type
- 5.8.3 South America Antibody Y-o-Y Growth Rate by End User
- 5.9 South America Antibody Share Comparison 2013–2028
- 5.9.1 South America Antibody Share by Region
- 5.9.2 South America Antibody Market Share by Product Type
- 5.9.3 South America Antibody Share by End User
- 5.1 South America Antibody Market by Product Type
- Chapter 6 APAC Antibody Market Overview
- 6.1 APAC Antibody Market by Product Type
- 6.1.1 APAC Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 6.1.2 APAC Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 6.1.3 APAC Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 6.2 APAC Antibody Market by End User
- 6.2.1 APAC Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 6.2.2 APAC Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 6.2.3 APAC Antibody Market Attractiveness Analysis by End User, 2012–2018
- 6.3 APAC Antibody Market Outlook by Region
- 6.3.1 APAC Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 6.3.2 APAC Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 6.3.3 APAC Antibody Market Attractiveness Analysis by Region, 2012–2018
- 6.4 APAC Antibody Market Outlook (2012-2028)
- 6.4.1 APAC Antibody Revenue (US$ Mn) (2012-2019)
- 6.4.2 APAC Antibody Revenue (US$ Mn) (2020-2028)
- 6.5 APAC Antibody Revenue (US$ Mn) by Regions
- 6.5.1 APAC Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 6.5.2 APAC Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 6.6 APAC Antibody Revenue (US$ Mn) by Product Type
- 6.6.1 APAC Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 6.6.2 APAC Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 6.7 APAC Antibody Revenue (US$ Mn) by End User
- 6.7.1 APAC Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 6.7.2 APAC Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 6.8 APAC Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 6.8.1 APAC Antibody Y-o-Y Growth Rate by Region
- 6.8.2 APAC Antibody Market Y-o-Y Growth Rate by Product Type
- 6.8.3 APAC Antibody Y-o-Y Growth Rate by End User
- 6.9 APAC Antibody Share Comparison 2013–2028
- 6.9.1 APAC Antibody Share by Region
- 6.9.2 APAC Antibody Market Share by Product Type
- 6.9.3 APAC Antibody Share by End User
- 6.1 APAC Antibody Market by Product Type
- Chapter 7 MEA Antibody Market Overview
- 7.1 MEA Antibody Market by Product Type
- 7.1.1 MEA Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2028)
- 7.1.2 MEA Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- 7.1.3 MEA Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- 7.2 MEA Antibody Market by End User
- 7.2.1 MEA Antibody Revenue (US$ Mn) Comparison by End User (2012-2028)
- 7.2.2 MEA Antibody Revenue (US$ Mn) Market Share by End User in 2018
- 7.2.3 MEA Antibody Market Attractiveness Analysis by End User, 2012–2018
- 7.3 MEA Antibody Market Outlook by Region
- 7.3.1 MEA Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- 7.3.2 MEA Antibody Revenue (US$ Mn) Market Share by Region in 2018
- 7.3.3 MEA Antibody Market Attractiveness Analysis by Region, 2012–2018
- 7.4 MEA Antibody Market Outlook (2012-2028)
- 7.4.1 MEA Antibody Revenue (US$ Mn) (2012-2019)
- 7.4.2 MEA Antibody Revenue (US$ Mn) (2020-2028)
- 7.5 MEA Antibody Revenue (US$ Mn) by Regions
- 7.5.1 MEA Antibody Revenue (US$ Mn) Comparison by Region (2012-2019)
- 7.5.2 MEA Antibody Revenue (US$ Mn) Comparison by Region (2020-2028)
- 7.6 MEA Antibody Revenue (US$ Mn) by Product Type
- 7.6.1 MEA Antibody Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- 7.6.2 MEA Antibody Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- 7.7 MEA Antibody Revenue (US$ Mn) by End User
- 7.7.1 MEA Antibody Revenue (US$ Mn) Comparison by End User (2012-2019)
- 7.7.2 MEA Antibody Revenue (US$ Mn) Comparison by End User (2020-2028)
- 7.8 MEA Antibody Y-o-Y Growth Rate Comparison 2013–2028
- 7.8.1 MEA Antibody Y-o-Y Growth Rate by Region
- 7.8.2 MEA Antibody Market Y-o-Y Growth Rate by Product Type
- 7.8.3 MEA Antibody Y-o-Y Growth Rate by End User
- 7.9 MEA Antibody Share Comparison 2013–2028
- 7.9.1 MEA Antibody Share by Region
- 7.9.2 MEA Antibody Market Share by Product Type
- 7.9.3 MEA Antibody Share by End User
- 7.1 MEA Antibody Market by Product Type
- Chapter 8 Global Antibody Market Manufacturer Profile
- 8.1 Overview of major market players
- 8.2 Company profiles
- 8.2.1 Novartis AG
- 8.2.1.1 Company Overview
- 8.2.1.2 Business Description
- 8.2.1.3 Product Portfolio
- 8.2.1.4 Key Financials
- 8.2.1.5 Key Developments
- 8.2.1.6 SWOT Analysis
- 8.2.2 Roche Holding AG
- 8.2.2.1 Company Overview
- 8.2.2.2 Business Description
- 8.2.2.3 Product Portfolio
- 8.2.2.4 Key Financials
- 8.2.2.5 Key Developments
- 8.2.2.6 SWOT Analysis
- 8.2.3 Johnson & Johnson
- 8.2.3.1 Company Overview
- 8.2.3.2 Business Description
- 8.2.3.3 Product Portfolio
- 8.2.3.4 Key Financials
- 8.2.3.5 Key Developments
- 8.2.3.6 SWOT Analysis
- 8.2.4 Takeda Pharmaceutical Company Limited
- 8.2.4.1 Company Overview
- 8.2.4.2 Business Description
- 8.2.4.3 Product Portfolio
- 8.2.4.4 Key Financials
- 8.2.4.5 Key Developments
- 8.2.4.6 SWOT Analysis
- 8.2.5 Amgen Inc.
- 8.2.5.1 Company Overview
- 8.2.5.2 Business Description
- 8.2.5.3 Product Portfolio
- 8.2.5.4 Key Financials
- 8.2.5.5 Key Developments
- 8.2.5.6 SWOT Analysis
- 8.2.6 Biogen Inc.
- 8.2.6.1 Company Overview
- 8.2.6.2 Business Description
- 8.2.6.3 Product Portfolio
- 8.2.6.4 Key Financials
- 8.2.6.5 Key Developments
- 8.2.6.6 SWOT Analysis
- 8.2.7 Bristol-Myers Squibb Company
- 8.2.7.1 Company Overview
- 8.2.7.2 Business Description
- 8.2.7.3 Product Portfolio
- 8.2.7.4 Key Financials
- 8.2.8 AbbVie Inc.
- 8.2.8.1 Company Overview
- 8.2.8.2 Business Description
- 8.2.8.3 Product Portfolio
- 8.2.8.4 Key Financials
- 8.2.8.5 Key Developments
- 8.2.8.6 SWOT Analysis
- 8.2.9 Sanofi
- 8.2.9.1 Company Overview
- 8.2.9.2 Business Description
- 8.2.9.3 Product Portfolio
- 8.2.9.4 Key Financials
- 8.2.9.5 Key Developments
- 8.2.9.6 SWOT Analysis
- 8.2.10 Eli Lilly and Company
- 8.2.10.1 Company Overview
- 8.2.10.2 Business Description
- 8.2.10.3 Product Portfolio
- 8.2.10.4 Key Financials
- 8.2.10.5 Key Developments
- 8.2.10.6 SWOT Analysis
- 8.2.1 Novartis AG
- Chapter 9 Methodology and Data Source
- 9.1 Methodology/Research Approach
- 9.1.1 Market Size Estimation
- 9.2 Market Breakdown and Data Triangulation
- 9.3 Data Source
- 9.3.1 Secondary Sources
- 9.3.2 Primary Sources
- 9.4 Disclaimer
- 9.1 Methodology/Research Approach
- List of Figures
- FIG. 1 Global Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 2 Global Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 3 Global Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 4 Global Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 5 Global Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 6 Global Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 7 Global Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 8 Global Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 9 Global Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 10 Global Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 11 Global Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 12 Global Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 13 Global Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 14 Global Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 15 Global Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 16 Global Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 17 Global Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 18 Global Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 19 Global Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 20 Global Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 21 Global Antibody Market Share Comparison by Region (2012-2019)
- FIG. 22 Global Antibody Market Share Comparison by Region (2020-2028)
- FIG. 23 Global Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 24 Global Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 25 Global Antibody Market Share Comparison by End User (2012-2019)
- FIG. 26 Global Antibody Market Share Comparison by End User (2020-2028)
- FIG. 27 North America Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 28 North America Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 29 North America Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 30 North America Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 31 North America Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 32 North America Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 33 North America Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 34 North America Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 35 North America Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 36 North America Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 37 North America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 38 North America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 39 North America Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 40 North America Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 41 North America Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 42 North America Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 43 North America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 44 North America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 45 North America Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 46 North America Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 47 North America Antibody Market Share Comparison by Region (2012-2019)
- FIG. 48 North America Antibody Market Share Comparison by Region (2020-2028)
- FIG. 49 North America Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 50 North America Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 51 North America Antibody Market Share Comparison by End User (2012-2019)
- FIG. 52 North America Antibody Market Share Comparison by End User (2020-2028)
- FIG. 53 Europe Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 54 Europe Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 55 Europe Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 56 Europe Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 57 Europe Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 58 Europe Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 59 Europe Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 60 Europe Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 61 Europe Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 62 Europe Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 63 Europe Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 64 Europe Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 65 Europe Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 66 Europe Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 67 Europe Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 68 Europe Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 69 Europe Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 70 Europe Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 71 Europe Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 72 Europe Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 73 Europe Antibody Market Share Comparison by Region (2012-2019)
- FIG. 74 Europe Antibody Market Share Comparison by Region (2020-2028)
- FIG. 75 Europe Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 76 Europe Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 77 Europe Antibody Market Share Comparison by End User (2012-2019)
- FIG. 78 Europe Antibody Market Share Comparison by End User (2020-2028)
- FIG. 79 South America Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 80 South America Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 81 South America Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 82 South America Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 83 South America Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 84 South America Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 85 South America Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 86 South America Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 87 South America Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 88 South America Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 89 South America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 90 South America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 91 South America Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 92 South America Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 93 South America Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 94 South America Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 95 South America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 96 South America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 97 South America Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 98 South America Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 99 South America Antibody Market Share Comparison by Region (2012-2019)
- FIG. 100 South America Antibody Market Share Comparison by Region (2020-2028)
- FIG. 101 South America Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 102 South America Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 103 South America Antibody Market Share Comparison by End User (2012-2019)
- FIG. 104 South America Antibody Market Share Comparison by End User (2020-2028)
- FIG. 105 APAC Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 106 APAC Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 107 APAC Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 108 APAC Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 109 APAC Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 110 APAC Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 111 APAC Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 112 APAC Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 113 APAC Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 114 APAC Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 115 APAC Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 116 APAC Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 117 APAC Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 118 APAC Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 119 APAC Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 120 APAC Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 121 APAC Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 122 APAC Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 123 APAC Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 124 APAC Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 125 APAC Antibody Market Share Comparison by Region (2012-2019)
- FIG. 126 APAC Antibody Market Share Comparison by Region (2020-2028)
- FIG. 127 APAC Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 128 APAC Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 129 APAC Antibody Market Share Comparison by End User (2012-2019)
- FIG. 130 APAC Antibody Market Share Comparison by End User (2020-2028)
- FIG. 131 MEA Antibody Revenue (US$ Mn) Market Share by Product Type in 2018
- FIG. 132 MEA Antibody Market Attractiveness Analysis by Product Type, 2012–2018
- FIG. 133 MEA Antibody Revenue (US$ Mn) Market Share by End User in 2018
- FIG. 134 MEA Antibody Market Attractiveness Analysis by End User, 2012–2018
- FIG. 135 MEA Antibody Revenue (US$ Mn) Market Share by Region in 2018
- FIG. 136 MEA Antibody Market Attractiveness Analysis by Region, 2012–2018
- FIG. 137 MEA Antibody Market Revenue (US$ Mn) (2012-2019)
- FIG. 138 MEA Antibody Market Revenue (US$ Mn) (2020-2028)
- FIG. 139 MEA Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- FIG. 140 MEA Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- FIG. 141 MEA Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- FIG. 142 MEA Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- FIG. 143 MEA Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- FIG. 144 MEA Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- FIG. 145 MEA Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- FIG. 146 MEA Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- FIG. 147 MEA Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- FIG. 148 MEA Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- FIG. 149 MEA Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- FIG. 150 MEA Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- FIG. 151 MEA Antibody Market Share Comparison by Region (2012-2019)
- FIG. 152 MEA Antibody Market Share Comparison by Region (2020-2028)
- FIG. 153 MEA Antibody Market Share Comparison by Product Type (2012-2019)
- FIG. 154 MEA Antibody Market Share Comparison by Product Type (2020-2028)
- FIG. 155 MEA Antibody Market Share Comparison by End User (2012-2019)
- FIG. 156 MEA Antibody Market Share Comparison by End User (2020-2028)
- List of Tables
- TABLE 1 Global Antibody Market Comparison by Product Type (2012-2028)
- TABLE 2 Global Antibody Market Comparison by End User (2012-2028)
- TABLE 3 Global Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 4 Global Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 5 Global Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 6 Global Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 7 Global Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 8 Global Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 9 Global Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 10 Global Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 11 Global Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 12 Global Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 13 Global Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 14 Global Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 15 Global Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 16 Global Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 17 Global Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 18 Global Antibody Market Share Comparison by Region (2012-2019)
- TABLE 19 Global Antibody Market Share Comparison by Region (2020-2028)
- TABLE 20 Global Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 21 Global Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 22 Global Antibody Market Share Comparison by End User (2012-2019)
- TABLE 23 Global Antibody Market Share Comparison by End User (2020-2028)
- TABLE 24 North America Antibody Market Comparison by Product Type (2012-2028)
- TABLE 25 North America Antibody Market Comparison by End User (2012-2028)
- TABLE 26 North America Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 27 North America Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 28 North America Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 29 North America Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 30 North America Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 31 North America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 32 North America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 33 North America Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 34 North America Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 35 North America Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 36 North America Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 37 North America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 38 North America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 39 North America Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 40 North America Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 41 North America Antibody Market Share Comparison by Region (2012-2019)
- TABLE 42 North America Antibody Market Share Comparison by Region (2020-2028)
- TABLE 43 North America Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 44 North America Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 45 North America Antibody Market Share Comparison by End User (2012-2019)
- TABLE 46 North America Antibody Market Share Comparison by End User (2020-2028)
- TABLE 47 Europe Antibody Market Comparison by Product Type (2012-2028)
- TABLE 48 Europe Antibody Market Comparison by End User (2012-2028)
- TABLE 49 Europe Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 50 Europe Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 51 Europe Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 52 Europe Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 53 Europe Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 54 Europe Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 55 Europe Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 56 Europe Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 57 Europe Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 58 Europe Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 59 Europe Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 60 Europe Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 61 Europe Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 62 Europe Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 63 Europe Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 64 Europe Antibody Market Share Comparison by Region (2012-2019)
- TABLE 65 Europe Antibody Market Share Comparison by Region (2020-2028)
- TABLE 66 Europe Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 67 Europe Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 68 Europe Antibody Market Share Comparison by End User (2012-2019)
- TABLE 69 Europe Antibody Market Share Comparison by End User (2020-2028)
- TABLE 70 South America Antibody Market Comparison by Product Type (2012-2028)
- TABLE 71 South America Antibody Market Comparison by End User (2012-2028)
- TABLE 72 South America Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 73 South America Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 74 South America Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 75 South America Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 76 South America Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 77 South America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 78 South America Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 79 South America Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 80 South America Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 81 South America Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 82 South America Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 83 South America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 84 South America Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 85 South America Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 86 South America Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 87 South America Antibody Market Share Comparison by Region (2012-2019)
- TABLE 88 South America Antibody Market Share Comparison by Region (2020-2028)
- TABLE 89 South America Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 90 South America Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 91 South America Antibody Market Share Comparison by End User (2012-2019)
- TABLE 92 South America Antibody Market Share Comparison by End User (2020-2028)
- TABLE 93 APAC Antibody Market Comparison by Product Type (2012-2028)
- TABLE 94 APAC Antibody Market Comparison by End User (2012-2028)
- TABLE 95 APAC Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 96 APAC Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 97 APAC Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 98 APAC Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 99 APAC Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 100 APAC Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 101 APAC Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 102 APAC Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 103 APAC Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 104 APAC Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 105 APAC Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 106 APAC Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 107 APAC Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 108 APAC Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 109 APAC Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 110 APAC Antibody Market Share Comparison by Region (2012-2019)
- TABLE 111 APAC Antibody Market Share Comparison by Region (2020-2028)
- TABLE 112 APAC Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 113 APAC Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 114 APAC Antibody Market Share Comparison by End User (2012-2019)
- TABLE 115 APAC Antibody Market Share Comparison by End User (2020-2028)
- TABLE 116 MEA Antibody Market Comparison by Product Type (2012-2028)
- TABLE 117 MEA Antibody Market Comparison by End User (2012-2028)
- TABLE 118 MEA Antibody Revenue (US$ Mn) Comparison by Region (2012-2028)
- TABLE 119 MEA Antibody Market Revenue (US$ Mn) (2012-2019)
- TABLE 120 MEA Antibody Market Revenue (US$ Mn) (2020-2028)
- TABLE 121 MEA Antibody Market Revenue (US$ Mn) Comparison by Region (2012-2019)
- TABLE 122 MEA Antibody Market Revenue (US$ Mn) Comparison by Region (2020-2028)
- TABLE 123 MEA Antibody Market Revenue (US$ Mn) Comparison by Product Type (2012-2019)
- TABLE 124 MEA Antibody Market Revenue (US$ Mn) Comparison by Product Type (2020-2028)
- TABLE 125 MEA Antibody Market Revenue (US$ Mn) Comparison by End User (2012-2019)
- TABLE 126 MEA Antibody Market Revenue (US$ Mn) Comparison by End User (2020-2028)
- TABLE 127 MEA Antibody Market Y-o-Y Growth Rate Comparison by Region (2013-2019)
- TABLE 128 MEA Antibody Market Y-o-Y Growth Rate Comparison by Region (2020-2028)
- TABLE 129 MEA Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2013-2019)
- TABLE 130 MEA Antibody Market Y-o-Y Growth Rate Comparison by Product Type (2020-2028)
- TABLE 131 MEA Antibody Market Y-o-Y Growth Rate Comparison by End User (2013-2019)
- TABLE 132 MEA Antibody Market Y-o-Y Growth Rate Comparison by End User (2020-2028)
- TABLE 133 MEA Antibody Market Share Comparison by Region (2012-2019)
- TABLE 134 MEA Antibody Market Share Comparison by Region (2020-2028)
- TABLE 135 MEA Antibody Market Share Comparison by Product Type (2012-2019)
- TABLE 136 MEA Antibody Market Share Comparison by Product Type (2020-2028)
- TABLE 137 MEA Antibody Market Share Comparison by End User (2012-2019)
- TABLE 138 MEA Antibody Market Share Comparison by End User (2020-2028)
- TABLE 139 Table Key Data Information from Secondary Sources
- ondemand_videoVideos
- 21236
- $3,495.00
- $5,100.00
- $7,200.00
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Takeda Pharmaceutical Company
- Amgen Inc.
- Biogen Inc.
- Bristol-Myers Squibb Company
- AbbVie Inc.
- settingsSettings